Dexmethylphenidate Hydrochloride; Serdexmethylphenidate Chloride Patent Expiration
Dexmethylphenidate Hydrochloride; Serdexmethylphenidate Chloride is Used for managing symptoms of Attention-Deficit Hyperactivity Disorder (ADHD) with Serdexmethylphenidate and Dexmethylphenidate. It was first introduced by Commave Therapeutics Sa
Dexmethylphenidate Hydrochloride; Serdexmethylphenidate Chloride Patents
Given below is the list of patents protecting Dexmethylphenidate Hydrochloride; Serdexmethylphenidate Chloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Azstarys | US10584112 | Methylphenidate-prodrugs, processes of making and using the same | Dec 09, 2037 | Commave Therap |
| Azstarys | US10584113 | Methylphenidate-prodrugs, processes of making and using the same | Dec 09, 2037 | Commave Therap |
| Azstarys | US10759778 | Methylphenidate-prodrugs, processes of making and using the same | Dec 09, 2037 | Commave Therap |
| Azstarys | US10858341 | Compositions comprising methylphenidate-prodrugs, processes of making and using the same | Dec 09, 2037 | Commave Therap |
| Azstarys | US10954213 | Compositions comprising methylphenidate-prodrugs, processes of making and using the same | Dec 09, 2037 | Commave Therap |
| Azstarys | US9079928 | Methylphenidate-oxoacid conjugates, processes of making and using the same | Jul 27, 2032 | Commave Therap |
Dexmethylphenidate Hydrochloride; Serdexmethylphenidate Chloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List